Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats
Recent data indicate that gamma-aminobutyric acid (GABA) is a modulator of behavioral responses to cocaine. The efficacy of gabapentin (a cyclic GABA analogue), tiagabine (a GABA reuptake inhibitor), or vigabatrin (an inhibitor of GABA transaminase and reuptake) to alter cocaine-seeking behavior and...
Gespeichert in:
Veröffentlicht in: | Psychopharmacologia 2007-05, Vol.192 (1), p.17-26 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 26 |
---|---|
container_issue | 1 |
container_start_page | 17 |
container_title | Psychopharmacologia |
container_volume | 192 |
creator | FILIP, Malgorzata FRANKOWSKA, Malgorzata ZANIEWSKA, Magdalena GOLDA, Anna PRZEGALINSKI, Edmund VETULANI, Jerzy |
description | Recent data indicate that gamma-aminobutyric acid (GABA) is a modulator of behavioral responses to cocaine.
The efficacy of gabapentin (a cyclic GABA analogue), tiagabine (a GABA reuptake inhibitor), or vigabatrin (an inhibitor of GABA transaminase and reuptake) to alter cocaine-seeking behavior and discriminative effects was examined in rats.
Rats were trained to press a lever for cocaine (0.5 mg/kg per infusion) paired with a cue (light + tone) using a fixed ratio (FR) 5 schedule of reinforcement. After extinction, the cocaine-seeking behavior was reinstated by cocaine priming (10 mg/kg). Another group of rats was trained to discriminate cocaine (10 mg/kg) from saline in a two-lever FR 20 task.
Vigabatrin (150-250 mg/kg) decreased cocaine-maintained responding, whereas tiagabine (10 mg/kg) significantly reduced responses on the "active" lever. Vigabatrin (150-250 mg/kg) significantly decreased responding to the cocaine-priming dose and a nonsignificant attenuation of cocaine-induced reinstatement was seen after tiagabine (5-10 mg/kg). Gabapentin (10-30 mg/kg) failed to alter maintenance of cocaine self-administration or drug-induced reinstatement. Pretreatment with either gabapentin, tiagabine, or vigabatrin resulted in neither reinstatement of cocaine seeking nor alterations in cocaine discrimination.
Our study demonstrates that vigabatrin (only at the 150 mg/kg dose) exerted inhibitory actions on cocaine-maintained responding and attenuated the reinstatement of extinguishing responding more effectively than gabapentin or tiagabine and with less evidence of motor impairment than the latter drugs. Present findings do not support a role for gabapentin or tiagabine for the possible treatment of cocaine relapse, whereas albeit limited effects of vigabatrin may be seen. |
doi_str_mv | 10.1007/s00213-006-0694-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70431289</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20285177</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-458353895cfb4968e35bbbb12d1ba19dc4ad21435c7a49995873d550ea2b72743</originalsourceid><addsrcrecordid>eNqFkc1rFTEUxYNY7Gv1D3AjQam7aD4nmeWzalsouNF1yCR3JHU-au7Mk_735vEeFgTxbAKXX87NySHkpeDvBOf2PXIuhWKcN4w3rWb2CdkIrSST3MqnZMO5UkwJ407JGeIdr9JOPyOnwkrTCNlsyK-PeQcFgULfQ1yQzj292n7YsjGPsORIU1m_1-lE4xxDnoDBbv4BiSIMPQtpzFPGpYQlVyRMiaaMseQ6rqMdUFzyuA4r_vHPE600PicnfRgQXhzPc_Lt86evl9fs9svVzeX2lkUtzMK0ccoo15rYd7ptHCjTVQmZRBdEm6IOSdbIJtqg27Y1zqpkDIcgOyutVufk7cH3vsw_V8DFj_WBMAxhgnlFb7lWQrr2v6Dk0hlhbQXf_AXezWuZaggvm8aopmq_9_U_KVHzSKNdhcQBimVGLND7-_p1oTx4wf2-YX9o2NeG_b5hv1__6mi8diOkxxvHSitwcQQCxjD0JUwx4yPnLJfWKPUbJoKtDA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218952548</pqid></control><display><type>article</type><title>Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>FILIP, Malgorzata ; FRANKOWSKA, Malgorzata ; ZANIEWSKA, Magdalena ; GOLDA, Anna ; PRZEGALINSKI, Edmund ; VETULANI, Jerzy</creator><creatorcontrib>FILIP, Malgorzata ; FRANKOWSKA, Malgorzata ; ZANIEWSKA, Magdalena ; GOLDA, Anna ; PRZEGALINSKI, Edmund ; VETULANI, Jerzy</creatorcontrib><description>Recent data indicate that gamma-aminobutyric acid (GABA) is a modulator of behavioral responses to cocaine.
The efficacy of gabapentin (a cyclic GABA analogue), tiagabine (a GABA reuptake inhibitor), or vigabatrin (an inhibitor of GABA transaminase and reuptake) to alter cocaine-seeking behavior and discriminative effects was examined in rats.
Rats were trained to press a lever for cocaine (0.5 mg/kg per infusion) paired with a cue (light + tone) using a fixed ratio (FR) 5 schedule of reinforcement. After extinction, the cocaine-seeking behavior was reinstated by cocaine priming (10 mg/kg). Another group of rats was trained to discriminate cocaine (10 mg/kg) from saline in a two-lever FR 20 task.
Vigabatrin (150-250 mg/kg) decreased cocaine-maintained responding, whereas tiagabine (10 mg/kg) significantly reduced responses on the "active" lever. Vigabatrin (150-250 mg/kg) significantly decreased responding to the cocaine-priming dose and a nonsignificant attenuation of cocaine-induced reinstatement was seen after tiagabine (5-10 mg/kg). Gabapentin (10-30 mg/kg) failed to alter maintenance of cocaine self-administration or drug-induced reinstatement. Pretreatment with either gabapentin, tiagabine, or vigabatrin resulted in neither reinstatement of cocaine seeking nor alterations in cocaine discrimination.
Our study demonstrates that vigabatrin (only at the 150 mg/kg dose) exerted inhibitory actions on cocaine-maintained responding and attenuated the reinstatement of extinguishing responding more effectively than gabapentin or tiagabine and with less evidence of motor impairment than the latter drugs. Present findings do not support a role for gabapentin or tiagabine for the possible treatment of cocaine relapse, whereas albeit limited effects of vigabatrin may be seen.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s00213-006-0694-7</identifier><identifier>PMID: 17256126</identifier><identifier>CODEN: PSYPAG</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>4-Aminobutyrate transaminase ; Amines - pharmacology ; Animals ; Behavior, Animal - drug effects ; Biological and medical sciences ; Cocaine ; Cocaine - administration & dosage ; Cocaine - pharmacology ; Cyclohexanecarboxylic Acids - pharmacology ; Discrimination Learning - drug effects ; Dopamine Uptake Inhibitors - administration & dosage ; Dopamine Uptake Inhibitors - pharmacology ; Dose-Response Relationship, Drug ; Drug abuse ; Drug dosages ; Drug self-administration ; Excitatory Amino Acid Antagonists - pharmacology ; Gabapentin ; gamma-Aminobutyric Acid - pharmacology ; Male ; Medical sciences ; Neuropharmacology ; Neurotransmitters ; Nipecotic Acids - pharmacology ; Pharmacology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Rats, Wistar ; Reinforcement Schedule ; Reinstatement ; Rodents ; Self Administration ; Tiagabine ; Transaminase ; Vigabatrin - pharmacology ; γ-Aminobutyric acid</subject><ispartof>Psychopharmacologia, 2007-05, Vol.192 (1), p.17-26</ispartof><rights>2007 INIST-CNRS</rights><rights>Springer-Verlag 2007</rights><rights>Springer-Verlag 2007.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-458353895cfb4968e35bbbb12d1ba19dc4ad21435c7a49995873d550ea2b72743</citedby><cites>FETCH-LOGICAL-c415t-458353895cfb4968e35bbbb12d1ba19dc4ad21435c7a49995873d550ea2b72743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18702753$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17256126$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FILIP, Malgorzata</creatorcontrib><creatorcontrib>FRANKOWSKA, Malgorzata</creatorcontrib><creatorcontrib>ZANIEWSKA, Magdalena</creatorcontrib><creatorcontrib>GOLDA, Anna</creatorcontrib><creatorcontrib>PRZEGALINSKI, Edmund</creatorcontrib><creatorcontrib>VETULANI, Jerzy</creatorcontrib><title>Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats</title><title>Psychopharmacologia</title><addtitle>Psychopharmacology (Berl)</addtitle><description>Recent data indicate that gamma-aminobutyric acid (GABA) is a modulator of behavioral responses to cocaine.
The efficacy of gabapentin (a cyclic GABA analogue), tiagabine (a GABA reuptake inhibitor), or vigabatrin (an inhibitor of GABA transaminase and reuptake) to alter cocaine-seeking behavior and discriminative effects was examined in rats.
Rats were trained to press a lever for cocaine (0.5 mg/kg per infusion) paired with a cue (light + tone) using a fixed ratio (FR) 5 schedule of reinforcement. After extinction, the cocaine-seeking behavior was reinstated by cocaine priming (10 mg/kg). Another group of rats was trained to discriminate cocaine (10 mg/kg) from saline in a two-lever FR 20 task.
Vigabatrin (150-250 mg/kg) decreased cocaine-maintained responding, whereas tiagabine (10 mg/kg) significantly reduced responses on the "active" lever. Vigabatrin (150-250 mg/kg) significantly decreased responding to the cocaine-priming dose and a nonsignificant attenuation of cocaine-induced reinstatement was seen after tiagabine (5-10 mg/kg). Gabapentin (10-30 mg/kg) failed to alter maintenance of cocaine self-administration or drug-induced reinstatement. Pretreatment with either gabapentin, tiagabine, or vigabatrin resulted in neither reinstatement of cocaine seeking nor alterations in cocaine discrimination.
Our study demonstrates that vigabatrin (only at the 150 mg/kg dose) exerted inhibitory actions on cocaine-maintained responding and attenuated the reinstatement of extinguishing responding more effectively than gabapentin or tiagabine and with less evidence of motor impairment than the latter drugs. Present findings do not support a role for gabapentin or tiagabine for the possible treatment of cocaine relapse, whereas albeit limited effects of vigabatrin may be seen.</description><subject>4-Aminobutyrate transaminase</subject><subject>Amines - pharmacology</subject><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cocaine</subject><subject>Cocaine - administration & dosage</subject><subject>Cocaine - pharmacology</subject><subject>Cyclohexanecarboxylic Acids - pharmacology</subject><subject>Discrimination Learning - drug effects</subject><subject>Dopamine Uptake Inhibitors - administration & dosage</subject><subject>Dopamine Uptake Inhibitors - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug abuse</subject><subject>Drug dosages</subject><subject>Drug self-administration</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Gabapentin</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters</subject><subject>Nipecotic Acids - pharmacology</subject><subject>Pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reinforcement Schedule</subject><subject>Reinstatement</subject><subject>Rodents</subject><subject>Self Administration</subject><subject>Tiagabine</subject><subject>Transaminase</subject><subject>Vigabatrin - pharmacology</subject><subject>γ-Aminobutyric acid</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkc1rFTEUxYNY7Gv1D3AjQam7aD4nmeWzalsouNF1yCR3JHU-au7Mk_735vEeFgTxbAKXX87NySHkpeDvBOf2PXIuhWKcN4w3rWb2CdkIrSST3MqnZMO5UkwJ407JGeIdr9JOPyOnwkrTCNlsyK-PeQcFgULfQ1yQzj292n7YsjGPsORIU1m_1-lE4xxDnoDBbv4BiSIMPQtpzFPGpYQlVyRMiaaMseQ6rqMdUFzyuA4r_vHPE600PicnfRgQXhzPc_Lt86evl9fs9svVzeX2lkUtzMK0ccoo15rYd7ptHCjTVQmZRBdEm6IOSdbIJtqg27Y1zqpkDIcgOyutVufk7cH3vsw_V8DFj_WBMAxhgnlFb7lWQrr2v6Dk0hlhbQXf_AXezWuZaggvm8aopmq_9_U_KVHzSKNdhcQBimVGLND7-_p1oTx4wf2-YX9o2NeG_b5hv1__6mi8diOkxxvHSitwcQQCxjD0JUwx4yPnLJfWKPUbJoKtDA</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>FILIP, Malgorzata</creator><creator>FRANKOWSKA, Malgorzata</creator><creator>ZANIEWSKA, Magdalena</creator><creator>GOLDA, Anna</creator><creator>PRZEGALINSKI, Edmund</creator><creator>VETULANI, Jerzy</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20070501</creationdate><title>Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats</title><author>FILIP, Malgorzata ; FRANKOWSKA, Malgorzata ; ZANIEWSKA, Magdalena ; GOLDA, Anna ; PRZEGALINSKI, Edmund ; VETULANI, Jerzy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-458353895cfb4968e35bbbb12d1ba19dc4ad21435c7a49995873d550ea2b72743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>4-Aminobutyrate transaminase</topic><topic>Amines - pharmacology</topic><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cocaine</topic><topic>Cocaine - administration & dosage</topic><topic>Cocaine - pharmacology</topic><topic>Cyclohexanecarboxylic Acids - pharmacology</topic><topic>Discrimination Learning - drug effects</topic><topic>Dopamine Uptake Inhibitors - administration & dosage</topic><topic>Dopamine Uptake Inhibitors - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug abuse</topic><topic>Drug dosages</topic><topic>Drug self-administration</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Gabapentin</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters</topic><topic>Nipecotic Acids - pharmacology</topic><topic>Pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reinforcement Schedule</topic><topic>Reinstatement</topic><topic>Rodents</topic><topic>Self Administration</topic><topic>Tiagabine</topic><topic>Transaminase</topic><topic>Vigabatrin - pharmacology</topic><topic>γ-Aminobutyric acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FILIP, Malgorzata</creatorcontrib><creatorcontrib>FRANKOWSKA, Malgorzata</creatorcontrib><creatorcontrib>ZANIEWSKA, Magdalena</creatorcontrib><creatorcontrib>GOLDA, Anna</creatorcontrib><creatorcontrib>PRZEGALINSKI, Edmund</creatorcontrib><creatorcontrib>VETULANI, Jerzy</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Psychopharmacologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FILIP, Malgorzata</au><au>FRANKOWSKA, Malgorzata</au><au>ZANIEWSKA, Magdalena</au><au>GOLDA, Anna</au><au>PRZEGALINSKI, Edmund</au><au>VETULANI, Jerzy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats</atitle><jtitle>Psychopharmacologia</jtitle><addtitle>Psychopharmacology (Berl)</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>192</volume><issue>1</issue><spage>17</spage><epage>26</epage><pages>17-26</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><coden>PSYPAG</coden><abstract>Recent data indicate that gamma-aminobutyric acid (GABA) is a modulator of behavioral responses to cocaine.
The efficacy of gabapentin (a cyclic GABA analogue), tiagabine (a GABA reuptake inhibitor), or vigabatrin (an inhibitor of GABA transaminase and reuptake) to alter cocaine-seeking behavior and discriminative effects was examined in rats.
Rats were trained to press a lever for cocaine (0.5 mg/kg per infusion) paired with a cue (light + tone) using a fixed ratio (FR) 5 schedule of reinforcement. After extinction, the cocaine-seeking behavior was reinstated by cocaine priming (10 mg/kg). Another group of rats was trained to discriminate cocaine (10 mg/kg) from saline in a two-lever FR 20 task.
Vigabatrin (150-250 mg/kg) decreased cocaine-maintained responding, whereas tiagabine (10 mg/kg) significantly reduced responses on the "active" lever. Vigabatrin (150-250 mg/kg) significantly decreased responding to the cocaine-priming dose and a nonsignificant attenuation of cocaine-induced reinstatement was seen after tiagabine (5-10 mg/kg). Gabapentin (10-30 mg/kg) failed to alter maintenance of cocaine self-administration or drug-induced reinstatement. Pretreatment with either gabapentin, tiagabine, or vigabatrin resulted in neither reinstatement of cocaine seeking nor alterations in cocaine discrimination.
Our study demonstrates that vigabatrin (only at the 150 mg/kg dose) exerted inhibitory actions on cocaine-maintained responding and attenuated the reinstatement of extinguishing responding more effectively than gabapentin or tiagabine and with less evidence of motor impairment than the latter drugs. Present findings do not support a role for gabapentin or tiagabine for the possible treatment of cocaine relapse, whereas albeit limited effects of vigabatrin may be seen.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>17256126</pmid><doi>10.1007/s00213-006-0694-7</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-3158 |
ispartof | Psychopharmacologia, 2007-05, Vol.192 (1), p.17-26 |
issn | 0033-3158 1432-2072 |
language | eng |
recordid | cdi_proquest_miscellaneous_70431289 |
source | MEDLINE; SpringerLink Journals |
subjects | 4-Aminobutyrate transaminase Amines - pharmacology Animals Behavior, Animal - drug effects Biological and medical sciences Cocaine Cocaine - administration & dosage Cocaine - pharmacology Cyclohexanecarboxylic Acids - pharmacology Discrimination Learning - drug effects Dopamine Uptake Inhibitors - administration & dosage Dopamine Uptake Inhibitors - pharmacology Dose-Response Relationship, Drug Drug abuse Drug dosages Drug self-administration Excitatory Amino Acid Antagonists - pharmacology Gabapentin gamma-Aminobutyric Acid - pharmacology Male Medical sciences Neuropharmacology Neurotransmitters Nipecotic Acids - pharmacology Pharmacology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Rats Rats, Wistar Reinforcement Schedule Reinstatement Rodents Self Administration Tiagabine Transaminase Vigabatrin - pharmacology γ-Aminobutyric acid |
title | Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A10%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diverse%20effects%20of%20GABA-mimetic%20drugs%20on%20cocaine-evoked%20self-administration%20and%20discriminative%20stimulus%20effects%20in%20rats&rft.jtitle=Psychopharmacologia&rft.au=FILIP,%20Malgorzata&rft.date=2007-05-01&rft.volume=192&rft.issue=1&rft.spage=17&rft.epage=26&rft.pages=17-26&rft.issn=0033-3158&rft.eissn=1432-2072&rft.coden=PSYPAG&rft_id=info:doi/10.1007/s00213-006-0694-7&rft_dat=%3Cproquest_cross%3E20285177%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218952548&rft_id=info:pmid/17256126&rfr_iscdi=true |